primePICCport

The primePICCport is used to administer systemic chemotherapy, long-term parenteral nutrition or long-term medication. This port system also permits the high-pressure application of a contrast medium and it’s slim design allows for placement in the arm.

 

 

Product Description

 

The pfm medical CT rated, power-injectable, primePICCport is placed using a similar procedure as a PICC, ultrasound-guided puncture with Modified Seldinger Technique and possible verification of positioning with the ECG Tip Technology. Our pfm medical primePICCport has aesthetic and functional advantages over a PICC.

Advantages of the primePICCport for your patient –

  • Unlike other Vascular Access lines, with a pfm medical primePICCport the patients hospital visits and planned nursing time is much less as there is no requirement for a weekly flush, dressing change, needle free or extension set change.
  • No additional protection needed when bathing or showering
  • Patients lifestyle can continue as normal including travel and participating in most sports
  • Compared to other Vascular Access Lines there is a lower risk of infection (1)
  • Less vein punctures are required for long term therapy which preserves and improves vessel health

Implantable ports from pfm medical are used with an EZ Huber™ safety needle. Together they form a complete system giving patients and users a high level of safety. This system includes a wide range of high quality port solutions for a broad spectrum of indications and patients.

Access with the Portacator® which provides improved port accessibility and patient safety.


Vascular Access Device Selection

Selection of the correct vascular access device is vital to ensure that the patient is provided with a tailored device suited to the treatment that they need.

How long is the patient’s treatment? What is the patient’s lifestyle like before and after treatment? How many times does the device need to be accessed?

  • Right Line
  • Right Time
  • Right Place
  • Right Patient
  • Right Training

Training and Education

pfm medical have an ongoing commitment to offering extensive and in-depth training and education, which plays a vital role for Patients, Practitioners and Clinicians.

Click here for more information.


Benefits –

Excellent plastic–titanium combination The special combination of two materials provide light weight and high safety.

Nitinol Soft-Tip Guidewire The Nitinol guidewire is anti-kinking and ensures a simple and smooth introduction of the device.

Suitable for high-pressure applications The pressure resistance of the systems allows the application of certain substances with high pressure.

Safe identification The radiopaque CT marking on the bottom of the port ensures safe identification as a high-pressure port.

Reduced risk of migration The low weight reduces the risk of migration and increases patient comfort.

Slim design The narrow shape of the port allows for its use for placement in the arm.

Easy placement Small dimensions for easy placement.

MRT-conditional Reduced artefact formation (up to 3.0T)

Connection mechanism The transparent click-connector for the simple and easy connection as well as secure and reliable fixation of catheter and port chamber.


Technical Data –

  • Pressure stability: up to max. 21 bar/300 psi with maximum flow rate of 5 ml/s (3 ml/s with catheter 4.8 F)
  • Length of catheter: 750 mm
  • Dimension: 24.0 x 20.5 x 10.3 mm (L x W x H)
  • Weight: 3.5 g
  • Residual volume chamber: 0.30 ml
  • Septum diameter: 8.0 mm
  • Puncuture frequency (non-coring 19-G needle): 600

Catheter PU soft 1.0 x 1.6 mm

  • Flow rate*: 14 ml/min.
  • Residual volume: 0.10 ml/10 cm Length of catheter

*19-G-needle, 0.9-%-NaCl solution, Length of catheter 40 cm, Gravitation altitude difference 100cm


Ordering Information –

Ref – Description – OD – ID – Catheter – Material –
61.636.09.077-ARM primePICCport 1.6mm 1.0mm 4.8F PU Soft

  1. Coady, K. et al (2015) A comparison of infections and complications in central venous catheters in adults with solid tumours. Journal of Vascular Access. 16(1):38-41.